Vital Health PodcastVital Health Podcast

Taking the Helm Mid Drug Pricing Maelstrom

View descriptionShare

In this Vital Health Podcast, Duane Schulthess speaks with Rachel King, the Interim CEO of the Biotechnology Innovation Organization (BIO), who is steering the organization through the increasingly choppy waters of the DC drug pricing debate. With mounting regulatory pressure from all angles towards the global biopharma sector, Washington DC’s BIO sits at the center of the tempest.

  • Rachel King comes to BIO with a wealth of experience as the former Chair of BIO’s Board of Directors. She has worked as a VC, and was both the co-founder and CEO of GlycoMimetics. She was also a senior VP at Novartis.
  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Vital Health Podcast

    121 clip(s)

Vital Health Podcast

Duane Schulthess, Managing Director of Vital Tran…
Social links
Follow podcast
Recent clips
Browse 121 clip(s)